TY - JOUR T1 - Prevalence of joint hypermobility, hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome in a university population: an observational study AU - Tuna, Filiz PY - 2020 DA - March Y2 - 2019 DO - 10.18621/eurj.466831 JF - The European Research Journal JO - Eur Res J PB - Prusa Medical Publishing WT - DergiPark SN - 2149-3189 SP - 120 EP - 129 VL - 6 IS - 2 LA - en AB - Objectives:To investigatethe prevalence of joint hypermobility classes, hypermobility spectrumdisorders, hypermobile Ehlers-Danlos syndrome and their relations with sex inauniversity population. They are notable topics in rehabilitation, since theyrepresents the basis for some secondary disability conditions. Methods: Three hundred andthirty-five students met theinclusion criteria (university students who are not disabled, without knowndisease, aged 18-25 years). Joint hypermobility were classified as generalized,peripheral and localized asymptomatic or hypermobility spectrum disorders.Hypermobile Ehlers-Danlos syndrome was defined according to; 1) Brightoncriteria with cut-off Beighton scoring ≥ 4/9, 2) Villefranche criteria withcut-off Beighton scoring ≥ 5/9, and 3) The 2017 International Classification ofEhlers-Danlos syndrome. Results: In total, 77.3% (n = 259) of participants had anyclass of joint hypermobility and 25.9% (n=87) of them had generalized class.Asymptomatic joint hypermobility and hypermobility spectrum disordersprevalence in a university population were found to be 38.8% and 38.5%,respectively. Generalized, peripheral, localized asymptomatic jointhypermobility and hypermobility spectrum disorders were found; 13.1%, 4.2%,21.5%, and 12.8%, 7.5%, 18.2%, respectively. Prevalence of hypermobileEhlers-Danlos syndrome according to three classifications were found to be;19.4%, 15.2%, and 1.2%, respectively. Conclusions: The most common classes are localized asymptomaticjoint hypermobility in women and localized hypermobility spectrum disorders inmen. Awareness of the prevalence of joint hypermobility, hypermobility spectrumdisorders and hypermobile Ehlers-Danlos syndrome in healthy young populationmay contribute prevention of disability. KW - Joint laxity KW - musculoskeletal complications KW - chronic pain KW - myopia KW - dental braces KW - soft tissue problems CR - 1. Beighton P, Solomon L, Soskolne C. Articular mobility in an African population. Ann Rheum Dis 1973;32:413-8. CR - 2. Simmonds JV, Herbland A, Hakim A, Ninis N, Lever W, Aziz Q, et al. Exercise beliefs and behaviours of individuals with Joint Hypermobility syndrome/Ehlers-Danlos syndrome-hypermobility type. Disabil Rehabil 2019;41:445-55. CR - 3. Krahe AM, Adams RD, Nicholson LL. Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome-hypermobility type. Disabil Rehabil 2018;40:1989-96. CR - 4. Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J,et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8-26. CR - 5. Bovet C, Carlson M, Taylor M. Quality of life, unmet needs, and iatrogenic injuries in rehabilitation of patients with Ehlers-Danlos Syndrome hypermobility type/Joint Hypermobility Syndrome. Am J Med Genet A 2016;170:2044-51. CR - 6. Gerwin RD. Benign joint hypermobility is not benign. Myopain 2015;23:11-2. CR - 7. Fikree A, Aktar R, Morris JK, Grahame R, Knowles CH, Aziz Q. The association between Ehlers-Danlos syndrome-hypermobility type and gastrointestinal symptoms in university students: a cross-sectional study. Neurogastroenterol Motil 2017;29:e12942. CR - 8. De Wandele I, Calders P, Peersman W, Rimbaut S, De Backer T, Malfait F, et al. Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum 2014;44:353-61. CR - 9. Scheper MC, Juul-Kristensen B, Rombaut L, ameckers EA, Verbunt J, Engelbert RH. Disability in adolescents and adults diagnosed with hypermobility-related disorders: a meta-analysis. Arch Phys Med Rehabil 2016;97:2174-87. CR - 10. Scheper MC, Nicholson LL, Adams RD, Tofts L, Pacey V. The natural history of children with joint hypermobility syndrome and Ehlers-Danlos hypermobility type: a longitudinal cohort study. Rheumatology (Oxford) 2017;56:2073-83. CR - 11. Scheper MC, de Vries JE, Juul-Kristensen B, Nollet F, Engelbert RH. The functional consequences of generalized joint hypermobility: a cross-sectional study. BMC Musculoskelet Disord 2014;15:243. CR - 12. Remvig L, Jensen DV, Ward RC. Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol 2007;34:804-9. CR - 13. Remvig L, Flycht L, Christensen KB, Juul-Kristensen B. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome. Am J Med Genet A 2014;164A:591-6. CR - 14. Barçak ÖF, Karkucak M, Capkın E, Karagüzel G, Dilber B, Dedeoğlu DD. Prevalence of generalized joint hypermobility and fibromyalgia syndrome in the children population of Trabzon: a Turkish study. Turk Phys Med Rehab 2015;61:6-11. CR - 15. Ofluoglu D, Gunduz OH, Kul-Panza E, Guven Z. Hypermobility in women with fibromyalgia syndrome. Clin Rheumatol 2006;25:291-3. CR - 16. Seçkin U, Tur BS, Yilmaz O, Yağci I, Bodur H, Arasil T. The prevalence of joint hypermobility among high school students. Rheumatol Int 2005;25:260-3. CR - 17. Yıldırım Y, Yılmaz S, Ayhan E, Saygı S, Yanaral F, Zubarioğlu UA, et al. [The frequency of joint hypermobility in healthy school children]. Türk Pediatri Arşivi. 2005;40:83-6. [Article in Turkish] CR - 18. Juul-Kristensen B, Røgind H, Jensen D, Remvig L. Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. Rheumatology (Oxford) 2007;46:1835-41. CR - 19. Grahame R, Bird H, Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000;27:1777-9. CR - 20. Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet 2017;175:148-57. CR - 21. Beighton P, Paepe AD, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31-7. CR - 22. Çakmakçı E, Çelik C, Karagöz A, Yücel M. [Hypermobility in the outpatients referred to the physical therapy clinic]. Turk J Phys Med Rehab 1998;1(3). [Article in Turkish] CR - 23. Russek LN, Errico DM. Prevalence, injury rate and, symptom frequency in generalized joint laxity and joint hypermobility syndrome in a “healthy” college population. Clin Rheumatol 2016;35:1029-39. CR - 24. Russek L, Errico D. The prevalence of generalized joint laxity and joint hypermobility syndrome among female college athletes. J Orthop Sports Phys Ther 2013;43:A5. CR - 25. Soper K, Simmonds JV, Kaz Kaz H, Ninis N. The influence of joint hypermobility on functional movement control in an elite netball population: a preliminary cohort study. Phys Ther Sport. 2015;16:127-34. CR - 26. Al-Rawi ZS, Al-Aszawi AJ, Al-Chalabi T. Joint mobility among university students in Iraq. Rheumatology 1985;24:326-31. CR - 27. Kulas Søborg M-L, Leganger J, Quitzau Mortensen L, Rosenberg J, Burcharth J. Establishment and baseline characteristics of a nationwide Danish cohort of patients with Ehlers-Danlos syndrome. Rheumatology (Oxford) 2017;56:763-7. CR - 28. Mishra M, Ryan P, Atkinson P, Taylor H, Bell J, Calver D, et al. Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol 1996;35:861-6. CR - 29. Hakim AJ, Sahota A. Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol 2006;24:521-33. CR - 30. Albayrak I, Yilmaz H, Akkurt HE, Salli A, Karaca G. Is pain the only symptom in patients with benign joint hypermobility syndrome? Clin Rheumatol 2015;34:1613-9. UR - https://doi.org/10.18621/eurj.466831 L1 - https://dergipark.org.tr/en/download/article-file/678666 ER -